For the Inventor, By the Inventor

Enter assignee name

San Diego, CA, United States of America

Quidel Corporation

USPTO Granted Patents = 88

% Expired Patents = 14.8

CIPO Patents = 7

EPO Patents = 6

Forward Citations = 3,313

Loading Chart...

Loading Chart...

131 inventors (with patents filed for the assignee):

Allan D Pronovost (18 out of 28 patents)

Hans R Boehringer (12 out of 14 patents)

Bruce L Jacono (9 out of 9 patents)

4. Paul Lambotte (8 out of 9 patents)

5. Jhobe Steadman (7 out of 9 patents)

6. Jeremy Jerome (7 out of 7 patents)

7. Mark Daquipa (7 out of 7 patents)

8. Jason McClure (6 out of 16 patents)

9. Paul J Lawrence (6 out of 32 patents)

10. Robert Reed (5 out of 8 patents)

11. Robert Weiller (5 out of 8 patents)

12. David Dickson Booker (5 out of 5 patents)

13. Michael Cerrito (5 out of 6 patents)

14. Cecille Ramirez (5 out of 6 patents)

15. Jan W Pawlak (5 out of 5 patents)

Core Competencies:

Immunoassay

Point-of-Care Testing

Fluid Flow

Disease Diagnostics

Analyte Detection

Microfluidic Devices

Blood Separation

Rapid Tests

Diagnostic Assays

Autoantibodies

Lateral Flow Assays

Enzyme Immunoassays

88 patents: Sort by Forward Citations

1. 12681016 - COMPOSITIONS AND METHODS FOR DETECTING AUTOANTIBODIES (2026-07-14),

2. 12174185 - Compositions and methods for detecting autoantibodies (2024-12-24),

3. 12055542 - System and methods for remote assessment of a sample assay for disease diagnostics (2024-08-06),

4. 11953428 - Method for reducing analyzer variability using a normalization target (2024-04-09),

5. 11846637 - Immunoassay test device with two fluid flow paths for detection and differentiation of two or more analytes (2023-12-19),

6. 11783563 - Software and algorithms for use in remote assessment of disease diagnostics (2023-10-10),

7. 11674961 - Extraction reagent for use in an assay for detection of group A (2023-06-13),

8. 11650200 - Device for whole blood separation (2023-05-16),

9. 11560584 - Phage-mediated immunoassay and methods for determining susceptibility of bacteria to antibiotic or probiotic agents (2023-01-24),

10. 11548938 - DbpA antibodies and uses thereof (2023-01-10),

11. 11446654 - Substrate with channels for controlled fluid flow (2022-09-20),

12. 11131670 - Immunoassay test device with two fluid flow paths for detection and differentiation of two or more analytes (2021-09-28),

13. 11131666 - System and apparatus for point-of-care diagnostics (2021-09-28),

14. 11061020 - Interactive test device and apparatus with timing mechanism (2021-07-13),

15. 10908145 - Device for whole blood separation (2021-02-02),

Company Overview

Quidel Corporation, based in San Diego, CA, specializes in the development and manufacturing of innovative diagnostic solutions for various diseases. The company focuses on immunoassay technologies and point-of-care testing, enabling rapid and accurate disease detection. Quidel's expertise extends to fluid flow and analyte detection, utilizing advanced microfluidic devices and blood separation techniques to enhance diagnostic capabilities. Their commitment to improving healthcare outcomes positions them as a leader in the field of disease diagnostics.

Profile summary synthesized from public USPTO records and patent filings.

Company Badge

USPTO Data Jan 1 1976 - Oct 20 2026

88 Patents

#70 in San Diego, CA

#985 in California

#4,240 in US

#8,693 in the World

San Diego, CA, United States of America

Quidel Corporation

Forward Citations = 3,313

131 inventors:

Allan D Pronovost (18 out of 28 patents)

Hans R Boehringer (12 out of 14 patents)

Bruce L Jacono (9 out of 9 patents)

4. Paul Lambotte (8 out of 9 patents)

5. Jhobe Steadman (7 out of 9 patents)

IDiyas Innovation Intelligence. (2026). Company Patent Portfolio: Quidel Corporation. Retrieved from https://idiyas.com/company/quidel

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]

Loading…